Shield Therapeutics Market Cap

Shield Therapeutics has a market cap or net worth of 28.15 million as of February 21, 2025. Its market cap has decreased by -38.46% in one year.

Market Cap

28.15M

Enterprise Value

37.55M

Revenue

16.99M

Ranking

n/a

PE Ratio

n/a

Stock Price

3.67

Market Cap Chart

Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 28.15M, a decrease of -83.42%. That is a compound annual growth rate of -18.11%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	28.15M	33.33%
Dec 31, 2024	21.12M	-59.70%
Dec 29, 2023	52.40M	186.53%
Dec 30, 2022	18.29M	-80.96%
Dec 31, 2021	96.06M	28.62%
Dec 31, 2020	74.69M	-64.39%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	181.48B
GSK plc	58.67B
Haleon	35.36B
Smith & Nephew	8.91B
Hikma Pharmaceuticals	5.09B
ConvaTec Group	5.01B
HUTCHMED (China)	1.98B
Oxford Nanopore Technologies	1.24B

Market Cap Rankings